Le Lézard
Classified in: Health
Subject: SVY

Bone Growth Stimulators (Orthopedic Devices) - Global Market Analysis and Forecast Model


NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Bone Growth Stimulators (Orthopedic Devices) - Global Market Analysis and Forecast Model

Read the full report: https://www.reportlinker.com/p05588798

Summary
Bone Growth Stimulators (Orthopedic Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.

When a bone is fractured, the body naturally generates a low-level electric field to stimulate healing.For some patients, however, the body's natural healing processes are ineffective, and fractures experience delayed or non-union.

Additionally, patients treated with spinal fusion procedures may have difficultly healing.A number of risk factors contribute to these outcomes, including osteoporosis, smoking, diabetes, obesity, and previously failed spinal fusion.

Bone Growth Stimulators have been developed in order to promote healing in patients who are at risk for failed unions of long bone fractures or for spinal fusion. These devices can be either implanted or external, and operate by applying electrical or ultrasonic current to the fracture or fusion site.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).

Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model

Currently marketed bone growth stimulators and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized bone growth stimulators market revenue by segment and market outlooks from 2015-2028.
- Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for bone growth stimulators market.
- Competitive dynamics insights and trends provided for bone growth stimulators market.

Understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.

In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Bioventus, DJO Global, Orthofix, Zimmer Biomet, Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope
This Market Model gives important, expert insight you won't find in any other source.

The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the bone growth stimulators marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy
The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the bone growth stimulators market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the bone growth stimulators market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific bone growth stimulators market from 2015-2028.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Read the full report: https://www.reportlinker.com/p05588798

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 08:14
Happiest Minds Technologies Limited (NSE: HAPPSTMNDS), a 'Born Digital. Born Agile', Mindful IT Company, today announced the new GenAI chatbot - 'hAPPI', developed by its Generative AI Business Services (GBS) unit for Happiest Health. A...

at 08:13
CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive...

at 08:10
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced final results from the HD cohort of the Phase 4 START study, demonstrating positive real-world effectiveness, safety, adherence and satisfaction with the...

at 08:07
La Roche-Posay is proud to announce that it was the fastest growing skincare brand in 20231, for the second year in a row! According to NielsenIQ, the industry leader in market CPG research, the brand ranked first among top 20 brands based on dollar...

at 08:07
Integral Molecular, a leader in providing safe research reagents for virology, announces the launch of its Virus Neutralization Assay Services enabling researchers to rapidly obtain high-quality data to advance their vaccines and...

at 08:05
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the launch of PEMRYDI RTU®, the first and only ready-to-use presentation of pemetrexed for injection. This product does not require reconstitution, dilution, or refrigeration,...



News published on and distributed by: